Literature DB >> 19389789

Premature foetal closure of the arterial duct: clinical presentations and outcome.

Marc Gewillig1, Stephen C Brown, Luc De Catte, Anne Debeer, Benedicte Eyskens, Veerle Cossey, Dominique Van Schoubroeck, Chris Van Hole, Roland Devlieger.   

Abstract

AIMS: The prevalence of intra-uterine ductal dysfunction is unknown and the clinical consequences are poorly understood. The aim of this study was to investigate the echocardiographic (ECHO) abnormalities and outcomes of this rare phenomenon. METHODS AND
RESULTS: Retrospective analysis of foetal (n = 602) and neonatal ECHO databases (n = 1477) between 1998 and 2007. Clinical and imaging studies were reviewed for pathology due to or associated with premature closure of the duct. Twelve cases were identified. Eight (1.3%) were diagnosed pre-natally at a median gestational age of 29.0 weeks (range: 20.0-37.5 weeks). Four neonates (0.3%) with significant cyanosis and absence of the arterial duct were also included. The most common ECHO features were: excessive right ventricular (RV) hypertrophy (100%), more than expected tricuspid and pulmonary regurgitation (100% and 92%, respectively), and right atrial dilation (75%). Premature induction of delivery was advised for five patients. Neonatal therapy consisted of observation and oxygen administration (n = 7), ventilation with pulmonary vasodilators (n = 5), and one required extracorporeal membrane oxygenation. There were three deaths due to respiratory failure with severe pulmonary hypertension. During follow-up, two children required additional right heart procedures and one developed a non-compaction cardiomyopathy.
CONCLUSION: Foetal premature closure of the arterial duct causes stress at different foetal ages and many different levels of the right heart and pulmonary circulation, resulting in a wide range of secondary pathology. Disproportionate RV hypertrophy is the most common finding. Clinical outcomes range from mild symptomatology to lethal respiratory insufficiency.

Entities:  

Mesh:

Year:  2009        PMID: 19389789     DOI: 10.1093/eurheartj/ehp128

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  22 in total

Review 1.  Fetal Ventricular Hypertrabeculation/Noncompaction: Clinical Presentation, Genetics, Associated Cardiac and Extracardiac Abnormalities and Outcome.

Authors:  Claudia Stöllberger; Christian Wegner; Josef Finsterer
Journal:  Pediatr Cardiol       Date:  2015-05-27       Impact factor: 1.655

Review 2.  Diagnosis and management of heart failure in the fetus.

Authors:  B Davey; A Szwast; J Rychik
Journal:  Minerva Pediatr       Date:  2012-10       Impact factor: 1.312

3.  Maternal diclofenac medication in pregnancy causing in utero closure of the fetal ductus arteriosus and hydrops.

Authors:  Aravind T Shastri; Dalia Abdulkarim; Paul Clarke
Journal:  Pediatr Cardiol       Date:  2012-08-08       Impact factor: 1.655

4.  Maternal paracetamol intake and fetal ductus arteriosus constriction/closure: comprehensive signal evaluation using the Austin Bradford Hill criteria.

Authors:  Manfred Hauben; Stephen Bai; Eric Hung; Kasia Lobello; Charles Tressler; Vincent P Zucal
Journal:  Eur J Clin Pharmacol       Date:  2021-01-07       Impact factor: 2.953

Review 5.  Left ventricular non-compaction and its cardiac and neurologic implications.

Authors:  Josef Finsterer
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

Review 6.  Bronchopulmonary dysplasia: A review of pathogenesis and pathophysiology.

Authors:  Renjithkumar Kalikkot Thekkeveedu; Milenka Cuevas Guaman; Binoy Shivanna
Journal:  Respir Med       Date:  2017-10-24       Impact factor: 3.415

7.  Treatment of patent ductus arteriosus with bidirectional flow in neonates.

Authors:  Patrick N Ethington; P Brian Smith; Lakshmi Katakam; Ronald N Goldberg; C Michael Cotten
Journal:  Early Hum Dev       Date:  2011-03-12       Impact factor: 2.079

8.  Diagnostic ultrasound features and outcome of restrictive foramen ovale in fetuses with structurally normal hearts.

Authors:  Orhan Uzun; Kadir Babaoglu; Yusuf I Ayhan; Marsham Moselhi; Fran Rushworth; Sue Morris; Bryan Beattie; Jarmilla Wiener; Michael J Lewis
Journal:  Pediatr Cardiol       Date:  2014-03-01       Impact factor: 1.655

9.  Selective serotonin reuptake inhibitor exposure constricts the mouse ductus arteriosus in utero.

Authors:  Christopher W Hooper; Cassidy Delaney; Taylor Streeter; Michael T Yarboro; Stanley Poole; Naoko Brown; James C Slaughter; Robert B Cotton; Jeff Reese; Elaine L Shelton
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-07-01       Impact factor: 4.733

Review 10.  Foetal ductus arteriosus constriction unrelated to non-steroidal anti-Inflammatory drugs: a case report and literature review.

Authors:  Giovanna Battistoni; Ramona Montironi; Jacopo Di Giuseppe; Luca Giannella; Giovanni Delli Carpini; Alessandra Baldinelli; Marco Pozzi; Andrea Ciavattini
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.